How is MammaPrint Different from Other Genomic Tests?
While there are other genomic tests available, such as Oncotype DX and Prosigna, MammaPrint is unique in its inclusion of both estrogen receptor-positive and estrogen receptor-negative breast cancers. Additionally, MammaPrint uses a 70-gene signature, whereas other tests may use different gene panels and algorithms. This distinction can influence the test’s predictive value and applicability in diverse patient populations.
